Loss of FOXO transcription factors in the liver mitigates stress-induced hyperglycemia

Mol Metab. 2021 Sep:51:101246. doi: 10.1016/j.molmet.2021.101246. Epub 2021 May 5.

Abstract

Objective: Stress-induced hyperglycemia is associated with poor outcomes in nearly all critical illnesses. This acute elevation in glucose after injury or illness is associated with increased morbidity and mortality, including multiple organ failure. Stress-induced hyperglycemia is often attributed to insulin resistance as controlling glucose levels via exogenous insulin improves outcomes, but the mechanisms are unclear. Forkhead box O (FOXO) transcription factors are direct targets of insulin signaling in the liver that regulate glucose homeostasis via direct and indirect pathways. Loss of hepatic FOXO transcription factors reduces hyperglycemia in chronic insulin resistance; however, the role of FOXOs in stress-induced hyperglycemia is unknown.

Methods: We subjected mice lacking FOXO transcription factors in the liver to a model of injury known to cause stress-induced hyperglycemia. Glucose, insulin, glycerol, fatty acids, cytokines, and adipokines were assessed before and after injury. Liver and adipose tissue were analyzed for changes in glycogen, FOXO target gene expression, and insulin signaling.

Results: Stress-induced hyperglycemia was associated with reduced hepatic insulin signaling and increased hepatic FOXO target gene expression while loss of FOXO1, 3, and 4 in the liver attenuated hyperglycemia and prevented hyperinsulinemia. Mechanistically, the loss of FOXO transcription factors mitigated the stress-induced hyperglycemia response by directly altering gene expression and glycogenolysis in the liver and indirectly suppressing lipolysis in adipose tissue. Reductions were associated with decreased IL-6, TNF-α, and follistatin and increased FGF21, suggesting that cytokines and FOXO-regulated hepatokines contribute to the stress-induced hyperglycemia response.

Conclusions: This study implicates FOXO transcription factors as a predominant driver of stress-induced hyperglycemia through means that include cross-talk between the liver and adipose, highlighting a novel mechanism underlying acute hyperglycemia and insulin resistance in stress.

Keywords: AKT; FOXO; Insulin resistance; Lipolysis; Stress-induced hyperglycemia.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / metabolism
  • Animals
  • Blood Glucose / analysis
  • Blood Glucose / metabolism
  • Forkhead Transcription Factors / deficiency*
  • Forkhead Transcription Factors / genetics
  • Gene Expression Regulation
  • Humans
  • Hyperglycemia / blood
  • Hyperglycemia / genetics*
  • Hyperglycemia / metabolism
  • Insulin Resistance / genetics*
  • Liver / metabolism
  • Male
  • Mice
  • Mice, Knockout
  • Signal Transduction / genetics
  • Stress, Physiological / genetics*

Substances

  • Blood Glucose
  • Forkhead Transcription Factors